Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Genentech
Company Monitoring Page for Genentech
latest headlines for company on cafepharma
Genentech's PD-L1 breakthrough star 'atezo' positioned to vault ahead on cancer
Fierce Biotech
Sun, 05/31/15 - 11:15 am
Tags:
Genentech
,
anti-PD-L1
,
atezolizumab
,
ASCO
10 Important Checkpoint Inhibitor Cancer Drug Abstracts from ASCO '15
TheStreet.com
Fri, 05/15/15 - 11:05 am
Tags:
ASCO
,
cancer
,
Merck
,
Keytruda
,
Bristol-Myers Squibb
,
Opdivo
,
Roche
,
Genentech
,
MPDL3280A
,
MEDI4736
,
AstraZeneca
A preview of the new lung cancer data Roche will debut at ASCO
BioPharma Dive
Fri, 05/15/15 - 09:34 am
Tags:
non-small cell lung cancer
,
ASCO
,
Roche
,
Genentech
,
MPDL3280A
,
PDL-1 inhibitors
How pharma is amping up R&D with gene sequencing
BioPharma Dive
Fri, 05/15/15 - 09:29 am
Tags:
R&D
,
gene sequencing
,
Regeneron
,
Pfizer
,
Genentech
,
Biogen
,
Roche
23andMe poaches another Genentech vet as it delves into biotech
Fierce Biotech
Thu, 04/2/15 - 11:49 am
Tags:
23andMe
,
diagnostics
,
biotech
,
Genentech
Genentech project to add 100 jobs
Fierce Pharma
Fri, 03/27/15 - 10:24 am
Tags:
Genentech
,
Roche
,
drug manufacturing
Genentech denies knowledge of distribution-related problems
BioPharma Dive
Thu, 03/5/15 - 11:12 am
Tags:
Genentech
,
distribution
,
Avastin
,
Herceptin
,
Rituxan
Genentech Distribution Shift for Cancer Meds Delays Patient Care: Survey
WSJ Pharmalot
Mon, 03/2/15 - 12:29 pm
Tags:
Genentech
,
Avastin
,
Rituxan
,
Herceptin
,
distribution
Regeneron Beats Genentech In Rare Face Off Over Diabetes-Related Vision Loss
Forbes
Thu, 02/19/15 - 10:38 am
Tags:
Regeneron
,
Genentech
,
diabetes
,
Eylea
,
Lucentis
,
DME
,
diabetic macular edema
FDA Grants Breakthrough Therapy Designation To Genetech’s Cancer Immunotherapy
Bidness Etc.
Tue, 02/3/15 - 09:07 am
Tags:
FDA
,
breakthrough therapies
,
Genentech
,
anti-PD-L1
,
MPDL3280A
,
non-small cell lung cancer
Exclusive: Constellation chops staff, plots go-it-alone strategy as Genentech option deadline looms
Fierce Biotech
Mon, 01/19/15 - 10:31 am
Tags:
Constellation Pharmaceuticals
,
Genentech
Surprise! With $60 Million Genentech Deal, 23andMe Has A Business Plan
Forbes
Tue, 01/6/15 - 11:29 am
Tags:
Genentech
,
23andMe
,
diagnostics
,
Google Ventures
Exelixis' Partners File New Drug Application For Cobemetinib - Welcome News But Little Impact
Seeking Alpha
Tue, 12/16/14 - 08:08 am
Tags:
Exelixis
,
cobemetinib
,
Roche
,
Genentech
Genentech's top-billing Lucentis users are also top-paid speakers: NYT
Fierce Pharma
Tue, 12/9/14 - 07:55 am
Tags:
Genentech
,
Lucentis
,
physician payments
New Drugs Treat Advanced Stages of a Common Skin Cancer
WSJ Pharmalot
Tue, 11/25/14 - 10:58 am
Tags:
basal cell carcinoma
,
Erivedge
,
Genentech
Roche's Genentech defends supply shift for top cancer drugs
Yahoo/Reuters
Tue, 11/25/14 - 09:37 am
Tags:
Roche
,
Genentech
,
cancer
,
Avastin
,
Herceptin
,
Rituxan
,
distribution
Major Medical Centers ask Congress to Probe Genentech Distribution Shift
WSJ Pharmalot
Tue, 11/11/14 - 03:41 pm
Tags:
Genentech
,
distribution
,
Ascension
FDA accepts sBLA for Lucentis label expansion
Seeking Alpha
Wed, 10/8/14 - 01:06 pm
Tags:
FDA
,
Lucentis
,
Roche
,
Genentech
,
diabetic retinopathy
Genentech Sales Reps Face Hospital Bans Over a Wholesale Change
WSJ Pharmalot
Fri, 10/3/14 - 07:32 pm
Tags:
Genentech
,
drug reps
,
hospitals
,
distribution
Genentech shift could prove costly for hospitals
Medical Marketing and Media
Thu, 10/2/14 - 08:06 am
Tags:
Genentech
Pages
« first
‹ previous
…
10
11
12
13
14
15
16
17
18
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
An earthquake would most likely shake a: idea, building, breeze
*
Fill in the blank.